Marco graduated from The University of Leicester in 2002 and after a period of working at the University of Siena, Italy, he returned to Leicester to complete a PhD in biological inorganic chemistry (2007) developing biologically responsive MRI contrast agents and luminescence lanthanide probes for molecular imaging. He completed two postdoctoral positions: University of Liège, Belgium, studying polymer bound/biologically responsive lanthanide complexes; Commissariat à l'Énergie Atomique (CEA) Grenoble, France, developing lanthanide quantum dot probes. In 2010 he joined The University of Liverpool working with Prof. Steve Rannard and Prof. Andrew Owen on Non-Attrition HAART nanoparticle therapies for HIV/AIDS Drug Delivery. During this time, Marco developed many of the technologies that underpinned the formation of the UoL owned spin-out company Tandem Nano Ltd, for which he is a co-founder. This included the cGMP clinical manufacture of candidate therapies for the world’s first human trial studies of orally-dosed HIV nanomedicines. In 2019 Marco took on a Lectureship position in the Department of Material Science and Engineering at The University of Sheffield before returning to Liverpool in July 2020 having been awarded a UKRI Future Leaders Fellowship.